Jinpei Zhou Selected Research

Jinpei Zhou Research Topics

Disease

19	Neoplasms (Cancer) 02/2022 - 07/2011
3	Inflammation (Inflammations) 11/2020 - 01/2019
3	Carcinoma (Carcinomatosis) 10/2012 - 04/2012
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2021 - 03/2020
2	Mitochondrial Diseases (Mitochondrial Disease) 11/2020 - 01/2020
2	Peripheral Nervous System Diseases (PNS Diseases) 11/2020 - 01/2020
2	Hemorrhage 12/2018 - 01/2017
2	Hypoglycemia (Reactive Hypoglycemia) 10/2017 - 06/2016
1	Bites and Stings (Sting) 04/2021
1	Neoplasm Metastasis (Metastasis) 04/2021
1	Infections 04/2021
1	Colorectal Neoplasms (Colorectal Cancer) 11/2020
1	Hyperalgesia 11/2020
1	Alzheimer Disease (Alzheimer's Disease) 11/2020
1	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2020
1	Nervous System Diseases (Neurological Disorders) 11/2020
1	Pancreatic Neoplasms (Pancreatic Cancer) 12/2019
1	Hematologic Neoplasms (Hematological Malignancy) 02/2019
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2019
1	Insulin Resistance 01/2018
1	Dyslipidemias (Dyslipidemia) 10/2017
1	Type 2 Diabetes Mellitus (MODY) 10/2017
1	Colonic Neoplasms (Colon Cancer) 08/2011
1	Breast Neoplasms (Breast Cancer) 08/2011
1	Leukemia 07/2011

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 01/2021 - 10/2016
4	Fluorouracil (Carac)FDA LinkGeneric 01/2021 - 04/2012
4	Biological ProductsIBA 01/2019 - 07/2011
3	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 06/2016
2	LigandsIBA 02/2022 - 01/2021
2	Phosphotransferases (Kinase)IBA 01/2021 - 02/2019
2	Interleukin-1 Receptor-Associated KinasesIBA 01/2021 - 03/2020
2	NAD (NADH)IBA 11/2020 - 01/2020
2	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2020 - 01/2019
2	betrixabanIBA 12/2018 - 01/2017
1	Monoclonal AntibodiesIBA 02/2022
1	InterferonsIBA 04/2021
1	Interferon Type IIBA 04/2021
1	Interleukin-6 (Interleukin 6)IBA 04/2021
1	CytokinesIBA 04/2021
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 04/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 12/2020
1	Nerve Growth Factor Receptors (Neurotrophin Receptors)IBA 12/2020
1	3,5-dimethylisoxazoleIBA 11/2020
1	Scavenger Receptors (Scavenger Receptor)IBA 11/2020
1	Cytotoxins (Cytolysins)IBA 11/2020
1	SP6616IBA 11/2020
1	Amyloid (Amyloid Fibrils)IBA 11/2020
1	Caspase 3 (Caspase-3)IBA 11/2020
1	pyrimidineIBA 11/2020
1	pyridazineIBA 03/2020
1	Proteolysis Targeting ChimeraIBA 01/2020
1	compound 17IBA 12/2019
1	Protein Kinase InhibitorsIBA 02/2019
1	PalladiumIBA 01/2019
1	Peptide Initiation Factors (Initiation Factor)IBA 01/2019
1	Eukaryotic Initiation Factor-4EIBA 01/2019
1	Transcription Factors (Transcription Factor)IBA 01/2018
1	Streptozocin (Streptozotocin)FDA Link 10/2017
1	EnzymesIBA 10/2017
1	GlucokinaseIBA 10/2017
1	AminesIBA 01/2017
1	Oxidoreductases (Dehydrogenase)IBA 01/2017
1	4,6-dinitro-o-cresol (DNOC)IBA 01/2017
1	imidazopyridineIBA 01/2017
1	Lysine (L-Lysine)FDA Link 01/2017
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2017
1	dihydroquinoxalinoneIBA 10/2016
1	Pharmaceutical PreparationsIBA 10/2016
1	TAK-875IBA 06/2016
1	ScopoletinIBA 08/2012
1	Nitric Oxide DonorsIBA 08/2011
1	licofeloneIBA 08/2011
1	AcidsIBA 07/2011
1	Dasatinib (BMS 354825)FDA Link 07/2011

Therapy/Procedure

5	Immunotherapy 02/2022 - 01/2019
3	Therapeutics 01/2021 - 10/2020
1	Precision Medicine 12/2020
1	Oral Administration 10/2017